Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsCecilia Furlong - Director of ...
Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study ...
reaching a market size of USD 69.1 billion by 2032 US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- Interventional Cardiovascular Devices Market industry Overview 2025 By Device Type (Stents ...
GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...
Four hospitalized patients in need of intravenous inotropes but not mechanical ... Datascope™ IABP balloon catheters (Size Fr 8/Fr 10–40/50 cc) and a Datascope™ IABP Console were used.
RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery platform, today ...
Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsTim Power - Head of IRChris Viehbacher ...
Comprehensive Insights into the Intravenous (IV) Therapy and Vein Access Market: A Detailed Study from 2025 to 2033 IV therapy and vein access devices market is categorized into implantable ports, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback